19 related articles for article (PubMed ID: 3374267)
1. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.
Orrú M; Guitart X; Karcz-Kubicha M; Solinas M; Justinova Z; Barodia SK; Zanoveli J; Cortes A; Lluis C; Casado V; Moeller FG; Ferré S
Neuropharmacology; 2013 Apr; 67():476-84. PubMed ID: 23261866
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.
Finn IB; Holtzman SG
Psychopharmacology (Berl); 1987; 93(4):428-34. PubMed ID: 3124175
[TBL] [Abstract][Full Text] [Related]
3. Role of adenosine receptors in caffeine tolerance.
Holtzman SG; Mante S; Minneman KP
J Pharmacol Exp Ther; 1991 Jan; 256(1):62-8. PubMed ID: 1846425
[TBL] [Abstract][Full Text] [Related]
4. CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.
Holtzman SG
Life Sci; 1991; 49(21):1563-70. PubMed ID: 1943461
[TBL] [Abstract][Full Text] [Related]
5. Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine.
Holtzman SG
Life Sci; 1983 Aug; 33(8):779-87. PubMed ID: 6888193
[TBL] [Abstract][Full Text] [Related]
6. Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.
Ferré S; Herrera-Marschitz M; Grabowska-Andén M; Casas M; Ungerstedt U; Andén NE
Eur J Pharmacol; 1991 Jan; 192(1):31-7. PubMed ID: 1828237
[TBL] [Abstract][Full Text] [Related]
7. Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats.
Finn IB; Holtzman SG
Life Sci; 1988; 42(24):2475-82. PubMed ID: 3374267
[TBL] [Abstract][Full Text] [Related]
8. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects.
Nehlig A; Daval JL; Debry G
Brain Res Brain Res Rev; 1992; 17(2):139-70. PubMed ID: 1356551
[TBL] [Abstract][Full Text] [Related]
9. Biochemical mechanism of caffeine tolerance.
Ammon HP
Arch Pharm (Weinheim); 1991 May; 324(5):261-7. PubMed ID: 1888264
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
